دورية أكاديمية
أعرض في EDS

Seroprevalence of hepatitis B virus co-infection among HIV-1-positive patients in North-Central Nigeria: The urgent need for surveillance.

التفاصيل البيبلوغرافية
العنوان: Seroprevalence of hepatitis B virus co-infection among HIV-1-positive patients in North-Central Nigeria: The urgent need for surveillance.
المؤلفون: Akindigh TM; Infectious Diseases Unit, Jos University Teaching Hospital, Jos, Nigeria., Joseph AO; Infectious Diseases Unit, Jos University Teaching Hospital, Jos, Nigeria., Robert CO; Department of Microbiology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria., Okojokwu OJ; Department of Microbiology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria., Okechalu JN; Department of Microbiology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria., Anejo-Okopi JA; Department of Microbiology, Faculty of Natural Sciences, University of Jos, Jos, Nigeria.
المصدر: African journal of laboratory medicine [Afr J Lab Med] 2019 Jun 27; Vol. 8 (1), pp. 622. Date of Electronic Publication: 2019 Jun 27 (Print Publication: 2019).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: AOSIS OpenJournals Country of Publication: South Africa NLM ID: 101603205 Publication Model: eCollection Cited Medium: Print ISSN: 2225-2002 (Print) Linking ISSN: 22252002 NLM ISO Abbreviation: Afr J Lab Med Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Durbanville, South Africa : AOSIS OpenJournals, [2012]-
مستخلص: We report the seroprevalence of hepatitis B surface antigen among HIV-positive patients at a clinic in North-Central Nigeria. Screening for hepatitis B virus was based on serological markers. Alanine aminotransferase levels and CD4+ T-lymphocyte counts were compared between patients. The study showed that 9.2% were positive for hepatitis B surface antigen with significant differences between alanine aminotransferase levels of patients with and without hepatitis B virus. We recommend a national surveillance system to monitor control efforts.
Competing Interests: The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
References: Virol J. 2005 Sep 28;2:82. (PMID: 16191199)
Afr Health Sci. 2012 Sep;12(3):312-7. (PMID: 23382745)
JAMA. 2000 Jan 5;283(1):74-80. (PMID: 10632283)
Lancet Infect Dis. 2007 Jun;7(6):402-9. (PMID: 17521593)
J Hepatol. 2010 Apr;52(4):508-13. (PMID: 20206400)
Niger J Clin Pract. 2015 Mar-Apr;18(2):163-72. (PMID: 25665986)
J Infect Dev Ctries. 2009 Jun 01;3(5):369-75. (PMID: 19759507)
J Hepatol. 1997 Jul;27(1):18-24. (PMID: 9252068)
J Hepatol. 2006;44(1 Suppl):S65-70. (PMID: 16338021)
AIDS. 2007 Jun 19;21(10):1301-8. (PMID: 17545706)
J Med Virol. 2016 Mar;88(3):455-60. (PMID: 26255632)
Ann Hepatol. 2008 Apr-Jun;7(2):152-6. (PMID: 18626434)
Saudi J Gastroenterol. 2012 Mar-Apr;18(2):81-6. (PMID: 22421711)
Pan Afr Med J. 2016 Mar 25;23:128. (PMID: 27279955)
Gastroenterology. 2004 Nov;127(5 Suppl 1):S5-S16. (PMID: 15508102)
J Hepatol. 2010 Apr;52(4):514-22. (PMID: 20207438)
J Hepatol. 2006;44(1 Suppl):S6-9. (PMID: 16352363)
Clin Gastroenterol Hepatol. 2007 Dec;5(12):1462-8. (PMID: 18054753)
Vaccine. 2012 Mar 9;30(12):2212-9. (PMID: 22273662)
Gut. 1996;38 Suppl 2:S5-12. (PMID: 8786055)
فهرسة مساهمة: Keywords: Alanine aminotransferase; Antiretroviral therapy; CD4+ T-lymphocytes; HIV; Serological markers; hepatitis B virus
تواريخ الأحداث: Date Created: 20190717 Latest Revision: 20240718
رمز التحديث: 20240718
مُعرف محوري في PubMed: PMC6620520
DOI: 10.4102/ajlm.v8i1.622
PMID: 31309044
قاعدة البيانات: MEDLINE
الوصف
تدمد:2225-2002
DOI:10.4102/ajlm.v8i1.622